iSpecimen Inc. Files 8-K with Corporate Updates

Ticker: ISPC · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1558569

Sentiment: neutral

Topics: corporate-filing, bylaws, financials

TL;DR

iSpecimen filed an 8-K for corporate changes and financials.

AI Summary

On July 9, 2025, iSpecimen Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws and the filing of Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Woburn, MA, and operates in the commercial physical & biological research sector.

Why It Matters

This filing indicates corporate housekeeping and the submission of financial information, which is crucial for investors to stay updated on the company's formal structure and financial status.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial events or strategic shifts that would inherently increase risk.

Key Players & Entities

FAQ

What specific amendments were made to iSpecimen Inc.'s Articles of Incorporation or Bylaws?

The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text of the 8-K.

What type of financial statements were filed with this 8-K?

The filing states that 'Financial Statements and Exhibits' were filed, but does not specify the period or type (e.g., quarterly, annual) of these statements.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 9, 2025.

What is iSpecimen Inc.'s primary business sector?

iSpecimen Inc. operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, with SIC code 8731.

Where are iSpecimen Inc.'s principal executive offices located?

iSpecimen Inc.'s principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding iSpecimen Inc. (ISPC).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing